• PAVAN KUMAR BABU Department of Government General Health Hospital, Kurnool, Andhra Pradesh, India
  • SUJIN S Department of , Kurnool Medical College, Kurnool, Andhra Pradesh, India.
  • AJAY RAIDU G Department of , Kurnool Medical College, Kurnool, Andhra Pradesh, India.
  • UMA SHANKAR Department of , Kurnool Medical College, Kurnool, Andhra Pradesh, India.



Aneurysmal Bone Cyst (ABC), 3% Polidocanol, Percutaneous Sclerotherapy, VAS (Visual Analog Sore)


Objectives: To study the clinical and radiological outcomes in patients treated with 3% polidocanol as a sclerosing agent in percutaneous sclerotherapy for aneurysmal bone cyst (ABC).

Methods: This is a single-centered retrospective study conducted in the Department of Orthopaedics at Kurnool Medical College with 23 patients from 2018 to 2021 over 3 years, where 3% polidocanol was used as a sclerosing agent in percutaneous sclerotherapy as a treatment option for ABC. Postoperatively, patients are evaluated based on clinical and radiological examinations.

Results: Clinically, patients were compared to their own Visual Analog Score (VAS) at the time of healing to the VAS score during their first visit. The mean VAS during the first visit was 7.6. At the time of healing, there were only two patients who scored a score of 1 on the VAS. Radiologically, plain radiographs were observed for ossification. 20 (86.9%) patients achieved complete ossification, 2 (8.69%) patients could achieve partial ossification.

Conclusion: With this study, we would like to present that percutaneous sclerotherapy with 3% polidocanol is effective both clinically and radiologically in the treatment of ABCs. Our institution has adopted sclerotherapy as part of salvage therapy and as the first line of treatment in treating ABC tumors.


Download data is not yet available.


MRI of bone and soft tissue tumors and tumorlike lesions. Differential diagnosis and atlas. AJNR Am J Neuroradiol. 2009 Jan;30(1):e16. doi: 10.3174/ajnr.A1149. PMCID: PMC7051742

Grahneis F, Klein A, Baur-Melnyk A, Knösel T, Birkenmaier C, Jansson V, et al. Aneurysmal bone cyst: A review of 65 patients. J Bone Oncol. 2019 Aug 6;18:100255. doi: 10.1016/j.jbo.2019.100255. PMID: 31463187; PMCID: PMC6706632

Deventer N, Deventer N, Gosheger G, de Vaal M, Vogt B, Budny T. Current strategies for the treatment of solitary and aneurysmal bone cysts: A review of the literature. J Bone Oncol. 2021 Jul 20;30:100384. doi: 10.1016/j.jbo.2021.100384

Rossi G, Mavrogenis AF, Papagelopoulos PJ, Rimondi E, Ruggieri P. Successful treatment of aggressive aneurysmal bone cyst of the pelvis with serial embolization. Orthopedics. 2021;35(6):e963-8. doi: 10.3928/01477447-20120525-43

Rastogi S, Varshney MK, Trikha V, Khan SA, Choudhury B, Safaya R. Treatment of aneurysmal bone cysts with percutaneous sclerotherapy using polidocanol. A review of 72 cases with long-term follow-up. J Bone Joint Surg Br. 2006 Sep;88(9):1212-6. doi: 10.1302/0301-620X.88B9.17829. PMID: 16943475

Brosjö O, Pechon P, Hesla A, Tsagozis P, Bauer H. Sclerotherapy with polidocanol for treatment of aneurysmal bone cysts. Acta Orthop. 2013 Oct;84(5):502-5. doi: 10.3109/17453674.2013.850013. PMID: 24171682; PMCID: PMC38221377. Marcove RC, Sheth DS, Takemoto S, Healey JH. The treatment of aneurysmal bone cyst. Clin Orthop Relat Res. 1995 Feb;(311):157-63. PMID: 76345718. Jain R, Bandhu S, Sawhney S, Mittal R. Sonographically guided percutaneous sclerosis using 1% polidocanol to treat vascular malformations. J Clin Ultrasound. 2002 Sep;30(7):416-23. doi: 10.1002/ jcu.10091. PMID: 12210459

Boriani S, De Iure F, Campanacci L, Gasbarrini A, Bandiera S, Biagini R, et al. Aneurysmal bone cyst of the mobile spine: Report on 41 cases. Spine (Phila Pa 1976). 2001 Jan 1;26(1):27-35. doi: 10.1097/00007632- 200101010-00007. PMID: 11148642

Puri A, Hegde P, Gulia A, Parikh M. Primary aneurysmal bone cysts. Bone Joint J. 2020 Feb;102-B(2):186-90. doi: 10.1302/0301-620X.102B2. BJJ-2019-1083.R1. PMID: 32009434

Puthoor D, Francis L, Ismail R. Is sclerotherapy with polidocanol a better treatment option for aneurysmal bone cyst compared to conventional curettage and bone grafting? J Orthop. 2021 May 21;25:265-70. doi: 10.1016/j.jor.2021.05.020

Jasper J, van der Heijden L, van Rijswijk CS, van de Sande MA. Efficacy of sclerotherapy with polidocanol (ethoxysclerol) in primary aneurysmal bone cysts in children and adolescents. J Pediatr Orthop. 2021;41(7):e555-62. doi: 10.1097/BPO.0000000000001839

Ulici A, Florea DC, Carp M, Ladaru A, Tevanov I. Treatment of the aneurysmal bone cyst by percutaneous intracystic sclerotherapy using ethanol ninety-five percent in children. Int Orthop.2018Jun;42(6):1413-9. doi: 10.1007/s00264-018-3841-y. PMID: 29492610

Shiels WE 2nd, Beebe AC, Mayerson JL. Percutaneous doxycycline treatment of juxtaphyseal aneurysmal bone cysts. J Pediatr Orthop. 2016;36(2):205-12. doi: 10.1097/BPO.0000000000000413

Terzi S, Gasbarrini A, Fuiano M, Brodano GB, Ghermandi R, Bandiera S, et al. Efficacy and safety of selective arterial embolization in the treatment of aneurysmal bone cyst of the mobile spine: A retrospective observational study. Spine (Phila Pa 1976). 2017 Aug 1;42(15):1130-8. doi: 10.1097/BRS.0000000000002017. PMID: 28009753

Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience. J Clin Oncol. 1992 Jan;10(1):5-15. doi: 10.1200/JCO.1992.10.1.5. PMID: 1370176



How to Cite

PAVAN KUMAR BABU, S. . S, AJAY RAIDU G, and UMA SHANKAR. “ROLE OF POLIDOCANOL IN PERCUTANEOUS SCLEROTHERAPY IN TREATMENT OF ANEURYSMAL BONE CYST – A SINGLE-CENTER STUDY”. Asian Journal of Pharmaceutical and Clinical Research, vol. 17, no. 7, July 2024, pp. 84-86, doi:10.22159/ajpcr.2024v17i7.50704.



Original Article(s)